AirStrip Intellectual Property Receives Key Patent Protection

AirStrip Intellectual Property Receives Key Patent Protection


[email protected]

AirStrip Technologies, the leader in mobility platform solutions delivering patient data to caregivers anytime, anywhere, announced today that intellectual property that operates as a foundation for the full AirStrip mobile patient monitoring platform is now protected by a U.S. patent. Issued to AirStrip on August 28, 2012, the methodology patent covers the company’s technology and process of mobilizing physiologic data to smartphones, tablets and other devices, a development that impacts both the enterprise and consumer-based mHealth ecosystem.

“As the first and only global company to offer FDA-cleared applications that deliver live and historic patient physiologic monitoring data to mobile devices, AirStrip has a responsibility to exercise its patent protection in ways that rapidly drive the evolution of mHealth in a uniform and positive direction,” AirStrip CEO Alan Portela stated. “Ultimately, this commitment will measurably improve patient safety, minimize risks in the provision of care, improve outcomes and encourage the migration to population health management. The patent allows us to offer our partners and clients the assurance that AirStrip will continue to innovate and lead the evolution of mobile health solutions and standards.”

Companies, health systems and application developers that have mobility solutions available or in development that display patient physiologic data – including numeric data, waveforms, and other parameters – are encouraged to work with AirStrip to more quickly evolve mobility as the foundation for clinical transformation.

Portela noted that the issuance of this patent, coupled with the much broader AirStrip IP portfolio, will serve to protect the integrity of mobile applications that operate in the mHealth space – adding that AirStrip will defend its intellectual property while encouraging partnerships with entities that adhere to established regulatory requirements and quality standards.

“AirStrip fully supports FDA development and oversight of medical application guidelines in the interests of safeguarding patients,” Portela added. “We will readily consider working with members of the mHealth community who demonstrate a similar level of commitment.”

AirStrip President and Chief Medical Officer Cameron Powell MD, who co-founded AirStrip Technologies with Chief Technology Officer Trey Moore, said the issuance of this first patent is the culmination of a development vision laid out over a decade ago in the creation of AppPoint, AirStrip’s groundbreaking, data-independent, native software development platform.

“AirStrip is founded upon the goal of establishing mobility as a standard of care. AirStrip pioneered developments in mHealth knowing that we would ultimately play a global leadership role in this process,” Dr. Powell said. “We take great pride in seeing this vision come to fruition, and welcome to the table those who recognize the need for uniting disparate information systems in ways that transform the healthcare experience and lead to better clinical outcomes.”

Addressing the most pressing needs of a rapidly evolving global healthcare system, AirStrip develops mobile technology that can drive enhanced clinician engagement, strengthened care coordination and improved clinical and financial performance. By unlocking, transforming and mobilizing live and historical patient information from existing monitoring devices and EHR systems to access on mobile devices regardless of operating system, AirStrip helps transcend the geographic and technological barriers that delay informed clinician action. The AirStrip platform supports an enterprise-wide solution with live and predictive analytics and unprecedented opportunities to improve the health of individuals and populations. AirStrip is backed by investments from Sequoia Capital, Qualcomm, Inc., and Hospital Corporation of America (HCA). Visit for more information.